Eliem Therapeutics Quick Ratio 2021-2024 | CLYM
Historical quick ratio values for Eliem Therapeutics (CLYM) over the last 10 years.
Eliem Therapeutics Quick Ratio Historical Data |
Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
2024-06-30 |
$0.00B |
$0.00B |
0.00 |
2024-03-31 |
$0.00B |
$0.00B |
0.00 |
2023-12-31 |
$0.00B |
$0.00B |
0.00 |
2023-09-30 |
$0.00B |
$0.00B |
0.00 |
2023-06-30 |
$0.00B |
$0.00B |
0.00 |
2023-03-31 |
$0.00B |
$0.01B |
0.00 |
2022-12-31 |
$0.00B |
$0.01B |
0.00 |
2022-09-30 |
$0.00B |
$0.01B |
0.00 |
2022-06-30 |
$0.00B |
$0.01B |
0.00 |
2022-03-31 |
$0.00B |
$0.01B |
0.00 |
2021-12-31 |
$0.00B |
$0.01B |
0.00 |
2021-09-30 |
$0.00B |
$0.01B |
0.00 |
2021-06-30 |
$0.00B |
$0.01B |
0.00 |
2021-03-31 |
$0.00B |
|
0.00 |
2020-12-31 |
$0.00B |
|
0.00 |
2020-09-30 |
$0.00B |
|
0.00 |
2020-06-30 |
$0.00B |
|
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.342B |
$0.000B |
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|